Search for: "WATSON PHARMACEUTICALSÂ "
Results 201 - 220
of 359
Sorted by Relevance
|
Sort by Date
19 Aug 2013, 12:00 am
Watson, chairman of Husch Blackwell, said the focused, on-campus programming supports the firm’s commitment to ongoing professional attorney development. [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol… [read post]
22 Jun 2011, 4:09 am
(BIOtechNow) US: Manager’s Amendment (and others) to H.R. 1249 — Second opinions in genetic diagnostic testing (Patent Docs) US: AMA, ACLU and their friends oppose (Leahy-Smith) America Invents Act (Patent Docs) US: Kaneka files new 337 complaint regarding Certain Coenzyme Q10 Products (ITC 337 Law Blog) Products Baytril (Enrofloxacin) – US: In a rare move, District Court extends 30-month stay on FDA ANADA approval: Bayer Healthcare v Norbrook (FDA Law Blog) Cialis (Tadalafil)… [read post]
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated protein from B… [read post]
13 Jul 2011, 3:04 am
(The SPC Blog) Doha+10: On November 14, 2011, a meeting at WIPO in Geneva to discuss the Doha Declaration (KEI) Docs at BIO: Session on IP challenges for personalised medicine (Patent Docs) France to reform its pharmaceutical regulatory system… with possible global implications! [read post]
13 May 2010, 4:58 pm
Watson Pharmaceuticals Inc. et al. [read post]
14 Apr 2018, 11:46 am
Watson Labs., Inc. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on Mylan’s… [read post]
25 Aug 2011, 3:42 pm
Watson said the fund could also include safe removal systems, medical research into improved diagnostic, treatment and patient care practices, and approaches to systems of compensation and support. [read post]
13 Dec 2010, 11:41 am
Watson said while workplace injuries in New South Wales are at their lowest levels in two decades, there is still more work to be done. [read post]
15 Jul 2011, 11:32 pm
Watson??? [read post]
15 Jul 2011, 11:32 pm
Watson??? [read post]
21 Jan 2011, 6:38 am
Senate (see our previous posts here and here) critical of the Agency’s recent characterization of the 12-year reference product exclusivity period provided by the Biologics Price Competition and Innovation Act of 2009 (“BPCIA”) as “marketing exclusivity” rather than “data exclusivity,” several generic drug manufacturers (Hospira, Momenta Pharmaceuticals, Hospira, Mylan Labs, Teva Pharmaceuticals, and Watson… [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
9 May 2011, 6:07 am
Caraco Pharmaceutical Laboratories, Ltd., 2011 U.S. [read post]
19 Apr 2011, 5:04 pm
Highlights this week included: Aricept (Donepezil HCI) – US: Lawsuit alleges false marking based on Orange Book ‘advertising’: Pharmaceutical Technologies v Eisai (FDA Law Blog) (Patent Docs) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
27 Apr 2018, 11:56 am
The existing creative computers he discusses are all narrow or specific AI systems that are programmed to solve particular problems, like systems from the 1980s that were programmed to design new microchips based on certain rules and IBM’s Watson, which is currently identifying novel drug targets for pharmaceutical research. [read post]
5 Oct 2011, 3:44 am
General Nagoya Protocol on biodiversity benefit-sharing has 64 signatories (IP Watch) Book review Monday: Development and Health in Poor Countries (Patent Baristas) EU: OHIM Boards of Appeal: pharmaceutical products and cosmetics: Case R 877/2010-2 (Class 46) India: Conducting a post-mortem on Astella’s Indian patent no: 234753 (Spicy IP) India: Delhi High Court passes ex-parte interim injunction against Symed Labs for alleged infringement of Indian Patent No: 221536: Vifor v… [read post]
5 Oct 2011, 3:44 am
General Nagoya Protocol on biodiversity benefit-sharing has 64 signatories (IP Watch) Book review Monday: Development and Health in Poor Countries (Patent Baristas) EU: OHIM Boards of Appeal: pharmaceutical products and cosmetics: Case R 877/2010-2 (Class 46) India: Conducting a post-mortem on Astella’s Indian patent no: 234753 (Spicy IP) India: Delhi High Court passes ex-parte interim injunction against Symed Labs for alleged infringement of Indian Patent No: 221536: Vifor v… [read post]
